Form D/A — Adze Biotechnology Inc

0001787508-25-000001 · filed Feb 19, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $15,000,000
Reported amount sold: $6,149,998
Minimum investment: $25,000
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Adze Biotechnology Inc
CIK: 1787508
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 2332 GALIANO STREET, 2ND FL
CORAL GABLES, FL 33134
Phone: 9177439401

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Sidney Hopps · Executive Officer

Miami, FL Find on LinkedIn ↗
Kenneth J. Templin · Executive Officer

Oak Park, IL Find on LinkedIn ↗
Gloria Olivier · Director

Rochester, MN Find on LinkedIn ↗
G. Patrick Sage, II · Director

Kalamazoo, MI Find on LinkedIn ↗
Gabriel Raviv · Director

Glenview, IL Find on LinkedIn ↗
Brendan Kenny · Director

Edmonton, A0 Find on LinkedIn ↗

Other filings from this issuer

Form D/A — Nov 17, 2025 — 0001787508-25-000004

View the original filing on SEC EDGAR ↗